Citigroup’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1M | Buy |
415,951
+155,433
| +60% | +$783K | ﹤0.01% | 2002 |
|
|
2025
Q1 | $1.69M | Buy |
260,518
+76,201
| +41% | +$494K | ﹤0.01% | 2206 |
|
|
2024
Q4 | $1.35M | Buy |
184,317
+69,899
| +61% | +$513K | ﹤0.01% | 2388 |
|
|
2024
Q3 | $857K | Buy |
114,418
+29,547
| +35% | +$221K | ﹤0.01% | 2660 |
|
|
2024
Q2 | $755K | Sell |
84,871
-1,039,860
| -92% | -$9.25M | ﹤0.01% | 2432 |
|
|
2024
Q1 | $11.4M | Buy |
1,124,731
+918,710
| +446% | +$9.31M | 0.01% | 840 |
|
|
2023
Q4 | $2.07M | Sell |
206,021
-51,432
| -20% | -$517K | ﹤0.01% | 1625 |
|
|
2023
Q3 | $2.41M | Buy |
257,453
+100,975
| +65% | +$946K | ﹤0.01% | 1376 |
|
|
2023
Q2 | $3.84M | Sell |
156,478
-142,619
| -48% | -$3.5M | ﹤0.01% | 1242 |
|
|
2023
Q1 | $6.96M | Buy |
299,097
+106,436
| +55% | +$2.48M | ﹤0.01% | 975 |
|
|
2022
Q4 | $4.88M | Sell |
192,661
-126,119
| -40% | -$3.19M | ﹤0.01% | 1068 |
|
|
2022
Q3 | $6.15M | Buy |
318,780
+97,130
| +44% | +$1.87M | ﹤0.01% | 1020 |
|
|
2022
Q2 | $5.65M | Buy |
221,650
+174,980
| +375% | +$4.46M | ﹤0.01% | 1069 |
|
|
2022
Q1 | $1.2M | Sell |
46,670
-66,592
| -59% | -$1.71M | ﹤0.01% | 2179 |
|
|
2021
Q4 | $4.74M | Buy |
113,262
+2,448
| +2% | +$102K | ﹤0.01% | 1320 |
|
|
2021
Q3 | $4.82M | Buy |
110,814
+7,325
| +7% | +$319K | ﹤0.01% | 1329 |
|
|
2021
Q2 | $4.89M | Buy |
103,489
+8,298
| +9% | +$392K | ﹤0.01% | 1427 |
|
|
2021
Q1 | $4.88M | Buy |
95,191
+73,869
| +346% | +$3.79M | ﹤0.01% | 1353 |
|
|
2020
Q4 | $571K | Buy |
21,322
+15,215
| +249% | +$407K | ﹤0.01% | 2545 |
|
|
2020
Q3 | $209K | Sell |
6,107
-4,800
| -44% | -$164K | ﹤0.01% | 2760 |
|
|
2020
Q2 | $447K | Buy |
10,907
+8,262
| +312% | +$339K | ﹤0.01% | 2636 |
|
|
2020
Q1 | $91K | Buy |
2,645
+1,200
| +83% | +$41.3K | ﹤0.01% | 3346 |
|
|
2019
Q4 | $18K | Buy |
+1,445
| New | +$18K | ﹤0.01% | 4530 |
|